MarketPeel
Insider Trading Intelligence
DM

Dennis Matheis

DRIO
DIRECTOR · DARIOHEALTH CORP. · CIK 0001817012
FILING MIX · LIFETIME100%/0%
BUYS
19
SELLS
0
TOTAL VALUE
$1.31M
COMPANIES
2
ACTIVE SINCE
Aug 2020
HOLDINGS NOW
1,061,074
AVG SELL PX
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 5 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Dennis Matheis, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+83.33%+11.37%+1.07%+10.30%+13.27%
14d6+33.33%-2.29%+2.16%-4.45%-7.07%
30d6+33.33%-0.84%+2.24%-3.09%-5.08%
60d6+33.33%-6.80%+6.61%-13.41%-22.04%
90d6+33.33%-16.45%+8.36%-24.81%-31.02%
180d6+33.33%-5.96%+11.27%-17.22%-31.87%
1y6(1 pending)+0.00%-36.66%+27.91%-64.56%-56.15%
2y6(4 pending)+0.00%-76.10%+36.90%-113.00%-113.00%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DRIO · 27,631 shares · as of Sep 11, 2025
038,15576,310114,465152,62020212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 0 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LUCD
LUCID DIAGNOSTICS INC.
PURCHASE
245,000$1.00$245.3K1,033,443May 20, 2026May 21, 2026View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASEGRANT
Stock grant
123,000788,443Feb 20, 2026Feb 24, 2026View →
DRIO
DARIOHEALTH CORP.
PURCHASEGRANT
Stock grant
20,00027,631Sep 11, 2025Sep 15, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASE
100,000$1.02$101.8K665,443Aug 20, 2025Aug 22, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASE
33,218$1.32$43.8K565,443May 22, 2025May 22, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASE
33,218$1.32$43.8K350,000May 22, 2025May 22, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASE
129,684$1.32$171.5K532,225May 21, 2025May 22, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASE
129,684$1.32$171.5K316,782May 21, 2025May 22, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASE
187,098$1.30$242.3K402,541May 20, 2025May 22, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASE
187,098$1.30$242.3K187,098May 20, 2025May 22, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASEGRANT
Stock grant
112,800162,725Feb 20, 2025Feb 21, 2025View →
LUCD
LUCID DIAGNOSTICS INC.
PURCHASEGRANT
Stock grant
241,500241,500May 8, 2024May 9, 2024View →
DRIO
DARIOHEALTH CORP.
PURCHASEGRANT
Stock grant
70,000152,620Mar 6, 2024Mar 8, 2024View →
DRIO
DARIOHEALTH CORP.
PURCHASE
50$1,000.00$50.0K50May 4, 2023May 8, 2023View →
DRIO
DARIOHEALTH CORP.
PURCHASEGRANT
Stock grant
35,00035,000May 18, 2022May 20, 2022View →
DRIO
DARIOHEALTH CORP.
PURCHASEGRANT
Stock grant
17,62082,620Jan 19, 2021Jan 21, 2021View →
DRIO
DARIOHEALTH CORP.
PURCHASEGRANT
Stock grant
17,62082,620Jan 19, 2021Mar 31, 2021View →
DRIO
DARIOHEALTH CORP.
PURCHASE
15,00065,000Aug 18, 2020Aug 20, 2020View →
DRIO
DARIOHEALTH CORP.
PURCHASEGRANT
Stock grant
20,00020,000Aug 18, 2020Aug 20, 2020View →
Other insiders · DRIO
Loading peer insiders…
About this filer
CIK 0001817012
ROLE
Director
PRIMARY
DRIO
COMPANIES
2
ACTIVE SINCE
Aug 2020
MARKETPEEL · /INSIDER/0001817012DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback